Related Experiment Video

Updated: Aug 10, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy

Barry J Maron1

  • 1Minneapolis Heart Institute Foundation, Minneapolis, Minnesota 55407, USA.

Cardiology in Review
|June 6, 2002
PubMed

Insights

Sudden unexpected death in hypertrophic cardiomyopathy (HCM) stems from ventricular tachyarrhythmias in unstable hearts. Implantable cardioverter-defibrillators offer effective prevention strategies for high-risk patients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pathology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden unexpected death, particularly in young, asymptomatic individuals.
  • The underlying mechanism involves ventricular tachyarrhythmias originating from an electrically unstable myocardial substrate.
  • This instability is characterized by disorganized cellular structure, ischemia, cell death, and fibrotic scarring.

Purpose of the Study:

  • To summarize the pathophysiology of sudden death in HCM.
  • To highlight the challenges in identifying high-risk patients.
  • To emphasize the availability of effective preventive strategies.

Main Methods:

  • Review of existing literature on HCM pathophysiology and sudden death.
  • Analysis of clinical challenges in risk stratification.
  • Evaluation of current treatment options for sudden death prevention.

Main Results:

  • Sudden death in HCM is linked to primary ventricular tachyarrhythmias.
  • Myocardial disorganization, ischemia, and scarring create an electrically unstable substrate.
  • Accurate risk identification remains a significant clinical challenge.

Conclusions:

  • Sudden unexpected death is a critical concern in hypertrophic cardiomyopathy.
  • Effective prevention strategies, notably the implantable cardioverter-defibrillator, are available for high-risk individuals.
  • Continued research is needed for precise risk stratification in HCM patients.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

A Surgical Method for Subvalvular Structure Intervention Through a Transaortic Approach in Normal Bama Pigs07:24

A Surgical Method for Subvalvular Structure Intervention Through a Transaortic Approach in Normal Bama Pigs

Published on: March 13, 2026

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...